RxDoctor Payments Data

Charles Hartzog, MD

Sports Medicine · Montgomery, ALNPI 1952388050

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (48.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Prime Surgical, LLC at 51.1% of the total. Reporting peaked in 2020 at $2,230 and has fallen 91.2% since, to $196 in 2024. That places this record below the midpoint for sports medicine clinicians in AL, where the typical reported total is $4,051.

$4,017in general payments, 2019–2025

Across 24 payments — averaging $167.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prime Surgical, LLC$2K
  • Arthrex$1K
  • Johnson & Johnson$515
  • Zimmer Biomet$113
  • Smith+Nephew$63
  • Medical Device Business Services, Inc.$13

What the payments were for

  • Travel & lodging$86422%
  • Food & beverage$1,21130%
  • Education$1,94248%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Prime Surgical, LLC6$2,051
Arthrex8$1,261
Johnson & Johnson6$515
Zimmer Biomet1$113
Smith+Nephew2$63
Medical Device Business Services, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,017 in reported general payments places this provider in the 45th percentile of 108 sports medicine providers in Alabama.

See all sports medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$235,201
Medicare patients
441
Services billed
3,022

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban165$34,858
Celecoxib314$5,146
Meloxicam910$3,232
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen197$1,761
Flurbiprofen31$1,162
Tramadol Hcl286$921
Nortriptyline Hcl108$813
Oxycodone Hcl139$790
Nabumetone33$629
Methylprednisolone50$508
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen69$500
Diclofenac Sodium11$409
Ketorolac Tromethamine22$361
Gabapentin44$198
Ciprofloxacin Hcl25$170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$515$34,858165 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 108 sports medicine providers in Alabama.

Other sports medicine in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →